Navigation Links
Scorpion Anti-Venom Speeds Children's Recovery
Date:5/13/2009

Available in Mexico but not in U.S., it could make ICU stays unnecessary, study suggests

WEDNESDAY, May 13 (HealthDay News) -- An anti-venom medication used in Mexico but not approved for use in the United States appears able to quickly and completely help children recover from the nerve poisoning caused by the bark scorpion's sting, a new study finds.

It typically took less than two hours for the irregular eye movements, involuntary thrashing of limbs, breathing difficulties and other symptoms to disappear in all eight children in the study who were given the drug after suffering a bite from a bark scorpion, according to the research lead by University of Arizona researchers.

Seven children who were also stung but given a placebo continued to have symptoms for more than four hours and needed heavy sedation and hospitalization to fully recover, the researchers say.

The children in the study, published in the May 14 edition of the New England Journal of Medicine, had all been brought into a Tucson, Ariz., pediatric intensive care unit for treatment following the sting. Most of the sting victims were under the age of 6.

"This study told us that the dangerous effects of bark scorpion venom can be reversed quickly with the right anti-venom," Dr. Leslie Boyer, principal investigator of the study and director of the Venom Immunochemistry, Pharmacology and Emergency Response Institute at The University of Arizona College of Medicine, said in a news release issued by the university. "One-hundred percent of the children who received it got better very quickly, meaning that using this anti-venom in the emergency room will make intensive care treatment unnecessary for most patients."

The anti-venom, while commercially available in Mexico, is considered an experimental drug in the United States and has not received approval from the U.S. Food and Drug Administration. Boyer said making the
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services
2. Peptide discovered in scorpion venom may hold key to secretory diseases
3. Patient Room of the Future Speeds Healing
4. New technique boosts protein NMR imaging speeds
5. Tamoxifen Speeds Diagnosis of ER-Negative Breast Cancer
6. New Technology Speeds GI Disease Diagnosis
7. Fujifilm Receives FDA Approval for Unity SpeedSuite(TM)
8. DDT Compound Speeds Breast Cancer Growth
9. Specialized System Speeds Heart Attack Treatment
10. Newer Antibiotic Speeds TB Healing
11. 200 Families of Children With Serious Eye Problems Benefit From Unique Gift Card Program at The Vision Center at Childrens Hospital Los Angeles

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scorpion Anti-Venom Speeds Children's  Recovery
Scorpion Anti-Venom Speeds Children's Recovery
(Date:12/1/2009)...Chevy Chase, MDWomen who have gestational glucose ...nal diabetes) exhibit multiple cardiovascular risk...ording to a new study accepted for publication in ...rinology & Metabolism ( JCEM ). , Researchers ...between gestational glucose intolerance and postpa...
(Date:12/1/2009)... The Centers for Disease Co...e United States is born with an autism spectrum di...e and improve sensory processing by playing the ne... Hunt from Vision Audio, Inc., a wonderful holiday... Joppa, MD (PRWEB) December...
(Date:12/1/2009)..., , TORONTO, Dec. 1 /PRNewswire/ - Sentinelle...I coils and 4D advanced visualization software, ex...is year,s Radiological Society of North America (R...2009 (Booth 5800, Hall A). ,, With the unique V...Variable Coil Geometry(TM), Sentinelle,s line of b...
(Date:12/1/2009)... Caregiving: Ready or Not h...oved ones , Cincinnati, O...on a mission—a mission to help families unde..., , , ,“While we hope our loved ones live l...that many people require care at some point, and t...
(Date:12/1/2009)... Free hearing aids will be ...entral Texas. , Austin, T...w.hearlifeagain.com ), a professional hearing heal...f the hearing impaired and their families, announc...ng” holiday giveaway. Each year, Estes Audi...
Breaking Medicine News(10 mins):Health News:Glucose intolerance in pregnancy associated with postpartum cardiovascular risk 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 2Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 3Health News:EASe Funhouse Video Game Helps Children with Autism Learn to Improve Sensory Processing 4Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 2Health News:Sentinelle Medical Introduces New Suite of Breast MRI Coils for GE, Siemens and Toshiba Scanners 3Health News:Aging Expert's New Book Helps Boomers Address Challenges of Caregiving 2Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2
...es by Grammy Award Winning Recording Artist Rich... BROOK, Ill., Nov. 3 Ronald McDonald House,Charit...Excellence,celebration on Saturday, November 1 in ...restigious awards to individuals,selected from acr...
...ne-modifying enzyme may calm down gene expression ...(PRWEB) October 29, 2008 -- A very difficult-to-tr...of a small but potent epigenetic change that launc...chers at Children,s Hospital Boston and the Dan...
...History Survey, a division of the new UI Institute... mosquitoes are more likely to be infected with vi...s can be found in the November issue of the Ameri..., along with Assistant Professor Michael Reiskind ...
...all author royalties earned from the sale of his n...sky Medicine, and the Search for a Cure," will be ...ren,s Hospital of Philadelphia. , "We are very pl...Hospital of Philadelphia," said Dr. Bob Schultz, d...
...zed Yield of 9.0%, LARGO, Fla., Nov. 3 The Unile...nture Exchange: UVI) Board of Directors,today decl...0.09 per common,share, payable November 28, 2008 t...ch on a annualized dividend rate of U.S. $0.36 per...
...cy physicians access to earn CME cred... and IRVING, Texas, Nov. 3 McGraw-Hill,Profession...rces for the,scientific and medical communities, h... Education (CME) credits for,learning modules on A...
Other Medicine News:Health News:Ronald McDonald House Charities(R) Awards of Excellence Honors Peter and Virginia Ueberroth, Dr. Catherine D. Deangelis and Lionel Whitehead 2Health News:Ronald McDonald House Charities(R) Awards of Excellence Honors Peter and Virginia Ueberroth, Dr. Catherine D. Deangelis and Lionel Whitehead 3Health News:Tackling Hard-to-treat Childhood Cancer by Targeting Epigenetic Changes 2Health News:Tackling Hard-to-treat Childhood Cancer by Targeting Epigenetic Changes 3Health News:Smaller mosquitoes are more likey to be infected with viruses causing human diseases 2Health News:Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 2Health News:McGraw-Hill Professional and American College of Emergency Physicians Roll Out CME Functionality On AccessEmergency Medicine 3
(Date:12/1/2009)...c. 1 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharma...urer and supplier of,modernized traditional Chines...announced that it has received approvals from the ...to produce Pediatric Fever and Cough Oral Liquid i...Z20093060) and Antibacterial,and Anti-inflammatory...
(Date:12/1/2009)...ewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (...eriod has expired under the Hart-Scott-Rodino (HSR...to Vanda,s agreement, dated October 12, 2009, with... effective. Expiration of the waiting period, and...ggers an upfront payment to Vanda of $200 million....
(Date:12/1/2009)...wire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI )...oprietary antibodies for the treatment of cancer, ...ed that Bayer Schering Pharma AG has exercised its...e agreement entered into on January 12, 2009 to de...id tumors. ,, Under the terms of the agreement,...
Breaking Medicine Technology:Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 1Red Cross Implements Change to Enhance Donor Safety for Younger Donors 59824 2The Advisory Board Company Schedules Second Quarter Conference Call for November 2 2009 59822 1The Advisory Board Company Schedules Second Quarter Conference Call for November 2 2009 59822 2IntraHealth to Lead 24300 Million USAID Project in Global Health Workforce Systems Strengthening 59820 1IntraHealth to Lead 24300 Million USAID Project in Global Health Workforce Systems Strengthening 59820 2
...onstrated Sustained Improvement in Signs and,Sympt...h One-Third,of Patients Achieving Disease Remiss...007 – One-year data show nearly,75 percent o...ritis,(RA) receiving golimumab (CNTO 148) and meth... 20 percent improvement in,arthritis symptoms (ACR...
...ain, June 15, 2007 /PRNewswire-FirstCall/ --,Brist...garding the,efficacy and safety of ORENCIA(R) (aba...vestigational study in children with juvenile,idio...response to,one or more disease-modifying anti- rh... or tumor necrosis factor (TNF) antagonists.,The r...
Other Medicine Technology:Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
...ies I Instrument program offers state-of-the-art q...while maintaining strength and durability. Low pro...ht joint spaces. Series I instruments are availabl...angle required for large and small joint arthrosco...
Medicine Products: